| Literature DB >> 26156140 |
Valeria Wallace-Salinas1, Daniel P Brink2, Dag Ahrén3, Marie F Gorwa-Grauslund4.
Abstract
BACKGROUND: Laboratory evolution is an important tool for developing robust yeast strains for bioethanol production since the biological basis behind combined tolerance requires complex alterations whose proper regulation is difficult to achieve by rational metabolic engineering. Previously, we reported on the evolved industrial Saccharomyces cerevisiae strain ISO12 that had acquired improved tolerance to grow and ferment in the presence of lignocellulose-derived inhibitors at high temperature (39 °C). In the current study, we used comparative genomics to uncover the extent of the genomic alterations that occurred during the evolution process and investigated possible associations between the mutations and the phenotypic traits in ISO12.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26156140 PMCID: PMC4496855 DOI: 10.1186/s12864-015-1737-4
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Sequencing, reference mapping and de novo assembly results (as reported by Genewiz Inc.)
| Sequencing | Count | |
|---|---|---|
| Ethanol Red | ISO12 | |
| Total no. of reads | 15,458,851 | 12,449,273 |
| Median PHRED score | 38.0 | 38.0 |
| Mean GC content | 38 % | 38 % |
|
| Count | |
| Ethanol Red | ISO12 | |
| No. of mapped reads | 15,341,613 (99.2 %) | 12,353,009 (99.2 %) |
| Average coverage | 185× | 153× |
|
| Count | |
| Ethanol Red | ISO12 | |
| No. of matched reads | 15,390,426 (99.6 %) | 12,195,728 (98.0 %) |
| Average read length (bp) | 147.6 | 151.1 |
| Total contigs assembled | 218 | 361 |
| Total bases in contigs | 11,492,342 | 11,356,874 |
| Average coverage | 301× | 196× |
| N50 (bp) | 95,106 | 67,943 |
Results of the variant calling and -analysis
| Variants (SNPs and INDELs) | Count | |
|---|---|---|
| Ethanol Red | ISO12 | |
| General statistics | ||
| Number of variants detected versus S288c | 78,901 | 78,133 |
| Number of variants unique to strain | 2240/78,901 | 1472/78,133 |
| Statistics of the strain-unique variants | ||
| Intergenic variants | 1293/2240 | 969/1472 |
| Coding region variants | 947/2240 | 503/1472 |
| Predicted effects of the coding region variantsa | ||
| Synonymous effects | 536 | 222 |
| Non-synonymous effects | 454 | 306 |
aIncluding overlapping ORFs
Fig. 1Significantly enriched Gene Ontology (GO) terms for the non-synonymous variants detected in ISO12 compared to ER (p < 0.05, Holm-Bonferroni corrected). Terms were sorted in three categories: Biological process, Cellular component and Molecular function. The enrichment analysis was performed using the YeastMine at Saccharomyces Genome Database (SGD). Note that the same ORF can figure in multiple bars; please refer to Additional file 4 for the full list of ORFs
Significantly enriched lipids in ISO12 compared to ER
| Metabolite | ER/ISO12 (Log2 ratio) | Lipid class |
|---|---|---|
| Hexacosanoic acid (Cerotic acid) | −1.7620 | Fatty Acids |
| Ergosta-5,7,22,24(28)-tetraene-3beta-ol | −1.6764 | Sterols |
| 1-hexadecanoyl-sn-glycerol | −1.0575 | Glycerolipids |
| 1-octadecanoyl-rac-glycerol + 0.634 | −1.8446 | Glycerolipids |
| 1-eicosanoyl-2-docosanoyl-sn-glycerol | −1.3991 | Glycerolipids |
| GPEtnNMe(18:1(9Z)/18:1(9Z)) + 4.829 | −1.3707 | Glycerophospholipids |
| 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) | −1.3500 | Glycerophospholipids |
| 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoserine | −1.3625 | Glycerophospholipids |
| CerP(d18:0/16:0) | −1.0380 | Sphingolipids |
Fig. 2Colony morphology of ER (a and c)) and ISO12 (b and d) when grown on glucose (a and b) and glycerol c and d. For growth on glucose the picture shows the bottom of the colony, while the surface is presented for growth on glycerol